Journal profile · CLINICAL NEUROLOGY
Neuro-Oncology Practice
ISSN 2054-2577 · eISSN 2054-2585 · Oxford University Press
Neuro-Oncology Practice: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 4.4 (journal website); hybrid open access; APC about USD 5,036; median 109 days to acceptance (76 articles, last 24 months); 134 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Neuro-Oncology Practice is published by Oxford University Press and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Glioma Diagnosis and Treatment, Brain Metastases and Treatment and Cancer survivorship and care, together about 52.5% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Neuro-Oncology Practice focuses on the clinical aspects of the subspecialty for practicing clinicians and healthcare specialists from a variety of disciplines including physicians, nurses, physical/occupational therapists, neuropsychologists, and palliative care specialists, who have focused their careers on clinical patient care and who want to apply the latest treatment advances to their practice. These include: Applying new trial results to improve standards of patient care Translating scientific advances such as tumor molecular profiling and advanced imaging into clinical treatment decision making and personalized brain tumor therapies Raising awareness of basic, translational and clinical research in areas of symptom management, survivorship, neurocognitive function, end of life issues and caregiving Neuro-Oncology Practice is now discoverable in PubMed®, via full-deposit indexing in PubMed Central® (PMC). Papers published in 2019 issues and going forwards will be deposited in PMC and full-text will be available after a 12-month embargo. Journal metrics Citation metrics Clarivate 2025 Impact Factor 2.5 2025 5 Year Impact Factor 3.0 Clinical Neurology (Rank by Impact Factor) 161/296 2025 Cited Half-Life 4.6 years 2025 Immediacy Index 0.6 2025 Eigenfactor Score 0.0024 2025 Article Influence Score 0.846 Scopus 2025 CiteScore 4.4 Neurology (Rank by CiteScore) 90/201 Oncology (Rank by CiteScore) 196/428 2025 Source Normalized Impact per Paper (SNIP) 1.067 Readership 2025 Full Text Usage 163,552 Peer Review and Production 2025 Median days from submission to first decision 25.5 days 2025 Median days from submission to final decision 42 days 2025 Median days from acceptance to publication 11 days About metrics
From the journal's Aims & Scope
Research area (LetPub): CLINICAL NEUROLOGY
Editor-in-chief Martin J.B. TaphoornPublisher website
Editorial board by country: 1 in mainland China (about 1%); most named United States 36, Australia 10, Netherlands 9, Germany 8, Italy 5 (87 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Glioma Diagnosis and TreatmentMedicine29%
- Brain Metastases and TreatmentMedicine15.4%
- Cancer survivorship and careMedicine8.1%
- Meningioma and schwannoma managementMedicine6.7%
- Cancer-related cognitive impairment studiesMedicine6.4%
- Childhood Cancer Survivors' Quality of LifeMedicine3.7%
- Palliative Care and End-of-Life IssuesMedicine3.2%
- Management of metastatic bone diseaseMedicine3.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Clinical Neurology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 3 |
| Minor | Clinical Neurology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PMCPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 4.4Publisher website ·
- 5-year impact factor (publisher) 2025
- 3Publisher website ·
- CiteScore 2026-06
- 4.4LetPub ·
- CiteScore (publisher) 2025
- 4.4Publisher website ·
- SJR 2026-06
- 0.95LetPub ·
- SNIP 2026-06
- 1.07LetPub ·
- h-index
- 46OpenAlex ·
- i10-index
- 308OpenAlex ·
- 2-year mean citedness
- 1.75OpenAlex ·
- Self-citation rate
- 12%LetPub ·
- Share of gold OA articles
- 42.91%LetPub ·
Volume
- Articles per year
- 98LetPub ·
- Articles per year (publisher)
- 2,019Publisher website ·
- Downloads per year (publisher) 2025
- 163,552Publisher website ·
Articles by year OpenAlex count · 1,004 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 97 | 70 | 16 |
| 2025 | 134 | 132 | 151 |
| 2024 | 130 | 127 | 464 |
| 2023 | 80 | 80 | 459 |
| 2022 | 100 | 100 | 857 |
| 2021 | 68 | 68 | 841 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
109 daysMedian, submission to acceptance · P25–P75 89 days – 144 days
- Acceptance to online
- median 10 days (76 articles)
- Submission to online
- median 122 days
- Sample
- 76 articles with submission and acceptance dates (244 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Submission to first decision 2025
- 25.5 daysPublisher website ·
- Submission to final decision 2025
- 42 daysPublisher website ·
- Acceptance to publication
- 11 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 5,036 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteAuthorship
- Authorship
Author guidelines page for Neuro-Oncology Practice with sections on Journal Policies, Charges, and Manuscript Preparation Instructions. Model summary
Instructions to Authors Journal Policies Charges Manuscript Preparation Instructions
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Oxford University Press
- ISSN
- 2054-2577
- Electronic ISSN
- 2054-2585
- Latest issue on the website
- Volume 13, Issue 4 (August 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
FAQ
Frequently asked questions about Neuro-Oncology Practice
What CAS zone is Neuro-Oncology Practice in?
In the 2025 upgraded edition of the CAS Journal Ranking, Neuro-Oncology Practice is in Zone 4 of Medicine, and in Zone 4 of the minor category Clinical Neurology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Neuro-Oncology Practice?
The journal's website gives an impact factor of 4.4 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 4.4, h-index 46.
How long does peer review take at Neuro-Oncology Practice?
Based on the dates recorded on 76 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 109 days (interquartile range 89–144 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Neuro-Oncology Practice based?
Of the 87 board members whose country the journal's board page names, 1 (about 1%) are in mainland China; the countries named most often are United States (36), Australia (10) and Netherlands (9). Counted from the institutions listed on the board page; for reference only.
Which databases index Neuro-Oncology Practice?
According to LetPub and DOAJ records, Neuro-Oncology Practice is indexed in ESCI and Scopus. The journal's website also lists PMC; that list has not been checked against each database.
Is Neuro-Oncology Practice open access, and what is the APC?
Neuro-Oncology Practice is a hybrid journal. For open-access publication: APC about USD 5,036.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .